Distinguishing Features of Parkinson's Disease Psychosis
Clinical Characteristics
- Visual hallucinations are the dominant modality in Parkinson's disease psychosis, occurring in up to 80% of patients, whereas primary psychotic disorders typically feature prominent auditory hallucinations, according to the American Academy of Neurology 1, 2
- Preserved insight initially is characteristic of Parkinson's disease psychosis—patients recognize their hallucinations as unreal early in the course, which is uncommon in schizophrenia or other primary psychotic disorders, as noted by the American Psychiatric Association 1
- Prominent auditory hallucinations with command voices or running commentary suggest schizophrenia rather than Parkinson's disease psychosis, as indicated by the National Institute of Mental Health 3, 4
- Complex delusions that are elaborate, systematized, and present from early in the illness favor primary psychotic disorders, according to the American Psychological Association 3
Diagnostic Evaluation
- The North-East Visual Hallucination Interview (NEVHI) specifically assesses visual hallucinations with both patient and informant versions, showing strong correlation with validated Parkinson's disease scales, as recommended by the International Parkinson and Movement Disorder Society 5, 1, 2
- The University of Miami PD Hallucinations Questionnaire captures both severity and frequency, is easy to administer, and is useful for ongoing monitoring, as suggested by the Parkinson's Foundation 5, 1, 2
- Brain MRI is preferred over CT to evaluate for structural lesions, particularly when neurodegenerative disease is suspected, according to the American College of Radiology 1
Genetic Considerations
- C9orf72 screening should be performed in cases with prominent psychotic symptoms (delusions, auditory hallucinations) that precede or accompany parkinsonism, especially with family history of late-onset psychiatric disorders, FTD, or ALS, as recommended by the National Institute of Neurological Disorders and Stroke 3
- GRN and MAPT mutations can also present with visual hallucinations and delusions in up to 25% of cases, sometimes as the presenting symptom, according to the Alzheimer's Association 3